MedPath

Dextromethorphan and Fluoxetine for the treatment of OCD

Phase 2
Recruiting
Conditions
Obsessive-compulsive disorder.
Obsessive-compulsive disorder
Registration Number
IRCT20090117001556N158
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Age between 18 to 60 years old
Diagnosis of OCD based on DSM-5
Score of >21 in Yale–Brown obsessive-compulsive scale (Y-BOCS)

Exclusion Criteria

Receiving any treatment up to 6 weeks before the start of the trial
Diagnosis of another psychiatric disorder

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.